Emergent Transcutaneous Embolization in an Advanced Carcinosarcoma
Department of Internal Medicine (FD, GGS, YR), University of Michigan, Ann Arbor, MichiganThe American Journal of the Medical Sciences (Impact Factor: 1.39). 11/2013; 346(5):435-7. DOI: 10.1097/MAJ.0b013e31829bce15
: Active hemorrhage is a life-threatening complication of advanced tumors. It often signifies the terminal stage of the disease and therefore is usually treated with palliative care. Transcutaneous arterial embolization (TAE) is a safe, noninvasive procedure that halts acute tumor-related bleeding thereby providing effective life-saving treatment for patients with non-operable tumors. Carcinosarcoma is an uncommon tumor that generally affects the head and neck, respiratory tract, colon, uterus, ovaries, and fallopian tubes. The authors present an interesting case of a rare manifestation in an unusual location. A 60-year-old Caucasian male, who presented with abdominal and groin pain, was found to have a large carcinosarcoma in the retroperitoneal space. The tumor was complicated with an active bleed. Since he was not a candidate for surgical intervention, a TAE was performed. Two days later, the patient was discharged to hospice where he was able to live out the rest of his life.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.